Whalen Wealth Management Inc. Invests $988,000 in Intuitive Surgical, Inc. $ISRG
by Mitch Edgeman · The Markets DailyWhalen Wealth Management Inc. purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) in the fourth quarter, Holdings Channel.com reports. The fund purchased 1,744 shares of the medical equipment provider’s stock, valued at approximately $988,000.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Brighton Jones LLC grew its position in Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after buying an additional 731 shares during the period. Sivia Capital Partners LLC boosted its stake in shares of Intuitive Surgical by 3.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock worth $504,000 after acquiring an additional 34 shares in the last quarter. Schnieders Capital Management LLC. grew its holdings in shares of Intuitive Surgical by 38.0% in the 2nd quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock worth $529,000 after acquiring an additional 268 shares during the period. Beacon Pointe Advisors LLC increased its stake in Intuitive Surgical by 48.8% in the 2nd quarter. Beacon Pointe Advisors LLC now owns 6,185 shares of the medical equipment provider’s stock valued at $3,361,000 after purchasing an additional 2,029 shares in the last quarter. Finally, EverSource Wealth Advisors LLC increased its stake in Intuitive Surgical by 30.2% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,750 shares of the medical equipment provider’s stock valued at $951,000 after purchasing an additional 406 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.
Intuitive Surgical Price Performance
Shares of NASDAQ ISRG opened at $452.07 on Friday. The company has a market cap of $160.54 billion, a PE ratio of 57.30, a price-to-earnings-growth ratio of 3.49 and a beta of 1.68. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $603.88. The company has a 50-day simple moving average of $487.43 and a 200-day simple moving average of $513.10.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. During the same quarter in the prior year, the firm posted $2.21 earnings per share. The company’s quarterly revenue was up 18.8% compared to the same quarter last year. On average, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.
Insider Buying and Selling
In other news, EVP Myriam Curet sold 421 shares of the firm’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $208,378.16. Following the sale, the executive vice president owned 409 shares in the company, valued at $202,438.64. This trade represents a 50.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Mark Brosius sold 2,362 shares of Intuitive Surgical stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total value of $1,177,882.16. Following the completion of the sale, the senior vice president directly owned 3,554 shares of the company’s stock, valued at approximately $1,772,308.72. This represents a 39.93% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 32,943 shares of company stock worth $17,279,568 in the last three months. 0.60% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
A number of analysts have commented on ISRG shares. HSBC boosted their target price on Intuitive Surgical from $644.00 to $653.00 and gave the stock a “buy” rating in a research report on Monday, January 26th. Raymond James Financial lifted their price target on Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a research note on Friday, January 23rd. TD Cowen upgraded shares of Intuitive Surgical to a “strong-buy” rating in a research report on Tuesday, January 27th. Royal Bank Of Canada increased their price objective on shares of Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a research note on Wednesday, December 17th. Finally, Wall Street Zen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $614.95.
View Our Latest Research Report on ISRG
About Intuitive Surgical
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Further Reading
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).